BPC-157, for example, has a half-life of hours, not days
If youre living with type 2 diabetes (T2D) or struggling with obesity , you may have heard about a new class of medications called GLP-1 receptor agonists (GLP-1 RAs)
Your provider is employed by or contracted with one of these entities based on your location
holds stock from Eli Lilly and receives research funding from Novo Nordisk
To manage side effects, try to take your dose around the same time each week
However, due to concerns for safety, quality, and effectiveness of compounded GLP1RAs, the American Diabetes Association (ADA) has issued guidance recommending switching individuals to different FDA-approved medications to achieve and maintain individualized glucose-lowering, weight management, and/or cardiovascular and kidney risk reduction goals when supply or access is limited [75]